James Johnston (@jljohnstonmd) 's Twitter Profile
James Johnston

@jljohnstonmd

UPMC Cardiology fellow | former @BrighamMedRes | Yale School of Medicine 2022

ID: 1286449747788730368

calendar_today23-07-2020 23:55:03

9 Tweet

76 Followers

123 Following

Joseph Ross (@jsross119) 's Twitter Profile Photo

Impressive STAT investigation by Katie Palmer & Mario Aguilar on FDA’s breakthrough device program, its promise and current misuse; thanks for highlighting my concerns about tying BDP to CMS coverage and the need to generate evidence of patient benefit statnews.com/2022/04/18/fda…

Reshma Ramachandran (@reshmagar) 's Twitter Profile Photo

A little surreal to see this, but immensely grateful to Kirk Williamson Mark Miller & everyone at Arnold Ventures for their support of our work with the Doctors for America FDA Task Force & @Yale_CRIT in advancing policies that truly protect our patients. arnoldventures.org/stories/physic…

Joseph Ross (@jsross119) 's Twitter Profile Photo

Congress is currently finalizing the medical device user fee amendment (MDUFA) act. Working w/ Vinay Rathi (Mass Eye and Ear), Sanket Dhruva (UCSF Cardiology) and Rita Redberg, we review the history of the legislation, raise some concerns and make ... (1/2) nejm.org/doi/full/10.10…

Yale CRRIT (@yale_crrit) 's Twitter Profile Photo

🚨 Now out in JAMA Internal Medicine is a study by Brigham and Women's Medicine Residents James Johnston w/Joseph Ross & Reshma Ramachandran which looked at how often U.S. FDA approved new drugs between 2018-2021 with missed pivotal trial primary efficacy endpoints & FDA's rationale for approval: jamanetwork.com/journals/jamai…

Osman Moneer (@osmanmoneer) 's Twitter Profile Photo

How can FDA & CMS align policies to ensure that medical device innovation is based on strong and representative evidence? In a new JAMA Cardiology Special Communication, we explore market authorization and coverage for Breakthrough cardiovascular🫀 devices. jamanetwork.com/journals/jamac…

How can FDA & CMS align policies to ensure that medical device innovation is based on strong and representative evidence? 

In a new <a href="/JAMACardio/">JAMA Cardiology</a> Special Communication, we explore market authorization and coverage for Breakthrough cardiovascular🫀 devices.

jamanetwork.com/journals/jamac…
JAMA Health Forum (@jamahealthforum) 's Twitter Profile Photo

Centers for Medicare & Medicaid Services (CMS) should consider strengthening premarket evidence requirements for breakthrough medical devices to improve patient care and inform treatment decisions. ja.ma/4fCTrOI

Centers for Medicare &amp; Medicaid Services (CMS) should consider strengthening premarket evidence requirements for breakthrough medical devices to improve patient care and inform treatment decisions. ja.ma/4fCTrOI
Osman Moneer (@osmanmoneer) 's Twitter Profile Photo

To facilitate adoption of new medical devices, CMS can award💰 extra payments 💰 on top of standard reimbursement. In JAMA Health Forum, we characterized the evidence considered by CMS when approving or denying applications for outpatient Medicare supplemental payments.

To facilitate adoption of new medical devices, CMS can award💰 extra payments 💰 on top of standard reimbursement.

In JAMA Health Forum, we characterized the evidence considered by CMS when approving or denying applications for outpatient Medicare supplemental payments.
Sachit Singal, MD (@sachitsingalmd) 's Twitter Profile Photo

To my family, wife (Tanvee Varma, MD), and friends—thank you for your belief in me To my dad specifically (my cardiology idol)—I inch a little more forward today as I continue to chase your footsteps I am elated to join MGH Cardiology Fellows as a cardiology fellow very soon! 🫀🩺

To my family, wife (<a href="/TanveeVarma/">Tanvee Varma, MD</a>), and friends—thank you for your belief in me

To my dad specifically (my cardiology idol)—I inch a little more forward today as I continue to chase your footsteps

I am elated to join <a href="/MGHCVFellows/">MGH Cardiology Fellows</a> as a cardiology fellow very soon! 🫀🩺